Technology And Equipment Tenders

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Everolimus (atc L01eg02)

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Etanercept (atc Code According to Who: L04ab01)

Open House Discount Contracts 2023-01

Procurement of Architectural Services - Dps Competition

Outsystems Services - Dynamic Purchasing System

Open House Original Discount Contracts 2023-05 - Emtricitabine/Tenofoviralafenamide/Rilpivirine (Odefsey(R))

Open House Original Discount Contracts 2023-04 - Emtricitabine/Tenofovir Disoproxil/Rilpivirine (Eviplera(R))

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Atovaquone, Atc P01ax06 for the Period 03/01/2023 - 02/28/2025

Open House Original Discount Contracts 2023-08 - Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy(R))

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Colecalciferol Sodium Fluoride, Atc A11cc80 for the Period 03/01/2023 - 02/28/2025